Skip to content

Asprin and Clopidogrel Dual Anti-platelets Therapy Is Enough for Acute Coronary Syndrome?with Hypertension Patients: A Cohort Study

Asprin and Clopidogrel Dual Anti-platelets Therapy Is Enough for Acute Coronary Syndrome?with Hypertension Patients: A Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PRCH-14004918
Enrollment
Unknown
Registered
2014-06-24
Start date
2010-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute coronary artery syndrome

Interventions

ACS:PCI

Sponsors

The Forth Military University, Tangdu Hospital Carddiovascular Department
Lead Sponsor

Eligibility

Sex/Gender
All
Age
47 Years to 84 Years

Inclusion criteria

Inclusion criteria: This study was a prospective, single registry specifically designed to determine the relation between platelet reactivity, blood coagulation state and subsequent clinical events in patients with acute myocardial infarction treated with aspirin and clopidogrel after successful drug-eluting stent implantation. We enrol1ed 57 ACS patients at our hospitals. All the patients at our hospital successfully treated with one or more drug-eluting stents approved by the US Food and Drug Administration (FDA). The patients who adequately loaded with aspirin and clopidogrel were eligible for enrollment.

Exclusion criteria

Exclusion criteria: The only major exclusion criteria were the occurrence of a major complication during the procedure or before platelet function testing, or if bypass surgery was planned after PCI.

Design outcomes

Primary

MeasureTime frame
k time;r time;k+r time;alpha angle;

Contacts

Public Contacti Xue
lxhlms@126.com+86 13669232188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026